Biochips Market - Top Companies and Manufacturers

  • Report ID: 2900
  • Published Date: Jul 23, 2024
  • Report Format: PDF, PPT

Companies Dominating the Biochips Landscape

top-features-companies
    • Dynamic Biosensors GmbH
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • PerkinElmer Inc.
    • Bio-Rad Laboratories, Inc.
    • Illumina, Inc.
    • ABTECH Scientific, Inc.
    • Standard BioTools Inc.
    • Merck KGaA
    • LI-COR, Inc.
    • Cepheid
    • Agilent Technologies, Inc.

Browse Key Market Insights with Data Illustration:

In the News

  • Bio-Rad Laboratories, Inc. announced a collaboration with Element Biosciences, Inc. to demonstrate the Bio-Rad SEQuoia RNA Sequencing Library Preparation portfolio with the Element AVITI Benchtop Sequencer. Using the new Avidity Sequencing chemistry on the Element AVITI Sequencing Platform, Bio-Rad's SEQuoia RNA Complete Stranded RNA Library Prep Kit and SEQuoia Express Stranded RNA Library Prep Kit are estimated to be easily used to achieve high RNA sequencing accuracy and repeatability across different samples and inputs.

  • Merck KGaA announced the partnership with Artios Pharma to jointly develop multiple precision oncology drugs over the next three years as part of a global research collaboration. By leveraging Artios' proprietary nuclease targeting discovery platform, the companies are projected to jointly identify multiple synthetic lethal targets for precision cancer drug candidates.


Author Credits:  Radhika Pawar


  • Report ID: 2900
  • Published Date: Jul 23, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of biochips is evaluated at USD 10.34 Billion.

The biochips market size was valued at USD 9.15 Billion in 2023 and is expected to exceed USD 52.61 Billion by the end of 2036, registering over 14.4% CAGR during the forecast period i.e., between 2024-2036. Worldwide growing prevalence of cancer, a rising proportion of communicable disorders, and an upsurge in the development and approval of novel drugs are the major factors driving the market growth.

North America is likely to dominate majority industry share by 2036, propelled by increasing frequency of cancer amongst several people, followed by the rising burden of numerous types of chronic disorders in the region.

Dynamic Biosensors GmbH, PerkinElmer Inc., Bio-Rad Laboratories, Inc., Illumina, Inc., ABTECH Scientific, Inc., Standard BioTools Inc., Merck KGaA, LI-COR, Inc., Cepheid, Agilent Technologies, Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying